Lecturer - Biomedical Science & Pharmacology. Academic Coordinator, Medicines Australia Continuing Education Program. Course Coordinator, Bachelor of Medicines Management (Professional Honours)
BSc, MSc, PhD
|Contact Campus||Sandy Bay Campus|
|Telephone||+61 3 6226 1005|
|Fax||+61 3 6226 2870|
Dr Liu graduated with a BSc (1990) and MSc (1993) in Veterinary Medicine from Northwest A&F University. He obtained his PhD in Pharmacology in 2000 from South China Agricultural University and completed a postdoctoral fellowship at the School of Medicine, the University of Auckland, New Zealand. Since 2004, he has served as a Research Fellow and Lecturer for the University of Auckland, Auckland University of Technology and now at the University of Tasmania. He is a Unit Coordinator, Course Coordinator and Academic Coordinator of Medicines Australia CEP program, with a teaching portfolio consisting of pharmacology, pharmaceutical science and related biomedicine subjects for undergraduate and postgraduate programs. As a principal investigator and the Group Leader of Cancer Pharmacology Research Group, he has research interests in cancer pharmacology, molecular pharmacology, experimental therapeutics, pharmacokinetics, drug transport & delivery, targeted therapy and systems pharmacology.
Dr Liu has taught a variety of service units in biomedical science, including pharmacology, anatomy, physiology, internal medicine, toxicology, quality use of medicines, pharmaceutical industry regulations and research methodology, for undergraduate programs of health professions (Pharmacy, Nursing, Midwifery, Medicine & Paramedicine) and biomedical sciences. He also teaches specialised units in cancer pharmacology and molecular toxicology for postgraduate programs. He obtained his Graduate Certificate in University Learning & Teaching at University of Tasmania, with a pedagogical research interest in the evaluation of e-Learning.
Course Coordinator: Bachelor of Medicines Management with Professional Honours (M4S)
Dr Liu's major research interests focus on pharmacological and pharmaceutical sciences. He has particular interests in cancer pharmacology, molecular pharmacology, experimental therapeutics, pharmacokinetics, drug transport & delivery, targeted therapy and systems pharmacology.
He is a Principal Investigator and the Group Leader of Cancer Pharmacology Research Group.
Research projects include profiling of membrane drug transporters in colorectal cancer patients, targeting copper transporters and organic cation transporters, WNT signalling-targeted therapy, exosome-based drug delivery and platinum anticancer drug-induced neuropathy, antitvascular and metal-based anticancer drug development, with funding support from Royal Hobart Hospital Research Foundation, Cancer Council Tasmania, University of Tasmania, Cancer Society of New Zealand, University of Auckland, NM McBeath Child Cancer Research Fund and Auckland Medical Research Foundation.
Dr Liu has published >30 peer-reviewed papers in various pharmacology and medical journals, including Current Cancer Drug Targets, Biochemical Pharmacology, Journal of Pharmacology and Experimental Therapeutics, and the British Journal of Cancer. To date, he has trained 4 PhD, 12 MSc/Honours, 3 postdoctoral staff and several visiting doctors. His research collaborators include Professors Geraghty D (University of Tasmania), Mercer J (Deakin University), McKeage M (University of Auckland), Chen M (Xi'an Jiaotong University) and Dr Nott L (Royal Hobart Hospital).He is a member of Australia Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT), American Association for Cancer Research and the treasurer of ASCEPT New Zealand section. He is an invited speaker to international conferences, NHRMC Project Grant Assessor, visiting professor to reputable universities, Review Editor for Frontiers in Nutrition, and a manuscript reviewer for several international journals.
Research Expertise / Specific Skills
Research Theme Areas
Prevention and management of chronic disease
Authorised by the Associate Head, Pharmacy
23 February, 2015